1

2

PRESENTATIONON

RETAIL MANAGEMNT

Retail DRUG STORE

3

INTRODUCTION

• Founded in 1886 in New Brunswick, New Jersey.

• Headquarters situated in New Brunswick for more than 115 years.

• International expansion started in 1919 with J&J Canada.

• Johnson & Johnson spread its roots to the world’s largest democracy, India, during the endemic post-independence turmoil of 1947.

• Consumer products like TEK toothbrushes, Johnson’s Baby Cream and Prickly Heat Powder followed suit.

• In September 1957, a new company, Johnson & Johnson India Ltd. was created and registered with twelve employees on its rolls.

4

MANAGEMENT OPPORTUNITIES

•Improving at the Customer Service Level

•Exploring New Business Models

•Improving Business Processes

•Providing effective cutting edge IT infrastructure and capabilities

5

FORWARD RETAIL PLANNIG ELEMENT

• Growth of retail drug stores in INDIA

• Scope of branded retail drug stores in INDIA

• Improving the supply chain management

• Availability and Convenience given to the customer

• PAN INDIA Presence

6

DISTINCTIVE ROLE IN MARKET

•Johnson & Johnson is the most comprehensive manufacturer of healthcare products, selling more than 100 different products in the consumer, pharmaceutical and professional markets.

• It has a reputation for delivering high-quality products at competitive prices.

•Rich dividends have led to innovations in the pharmaceutical industry, surgical science and diagnostics industry, and have also earned it an important place in virtually every household.

7

OWNERS APTITUDE

8

• Training and working

• Technology transfer

• Managing stability samples and data, preparing reports for stability and feasibility

• Analytical abilities

BUSINESS OBJECTIVES REQUIRING STRATEGY

Johnson & Johnson Reviews Growth Strategies for Medical Devices & Diagnostics and Consumer Businesses (heading)

1.Senior leaders from the company are outlining strategies for two of the business segments that will enable the company to capitalize on growing demand in the $4 trillion global market for health care products and services.

2.Recent product launches, development pipelines, and market strategies that these businesses are deploying to achieve long-term, faster-than-market, growth rates across their business.

3.Robust Pipelines Across Seven MD&D Franchises Poised to Deliver innovation and growth.

9

MERCHANDISE STRATEGY OF BUSINESS

10

1. Unlike specialty stores, most chain drug retailers aren't merchandising the products by brand. J&J is one exception. The chain merchandises the Baby Products line, as well as other lines, as a group in the chain's 8-foot infant care section.

2. The chain also has added smaller specialty lines, such as Pure Baby's cradle cap shampoo and eczema bath care, to its lineup.

3. a) In the drug channel, private label products commanded nearly 38 percent of sales in the $15 million baby oil category

b) Private label products accounted for 27 percent of sales in the $22.1 million baby powder category

c) 40 percent of sales in the $23 million petroleum jelly category and 22 percent of sales in the $40 million bubble bath segment

4. private label continues to be a big force within the shampoo/conditioner, powder, oil, lotion and bath segments.

BUSINESS PROMOTION ELEMENTS

4 Ps of Marketing, which are the controllable elements

Product - The first element of the 4 Ps of marketing focuses on your individual goods and their product line. Product includes services

Place [Distribution] - The next of the 4 Ps of marketing focuses on getting product to your customer.

Promotion - This element of the 4 Ps of marketing focuses on communicating with your customer.

Price - The successful producer of an article sells it for more than it costs him to produce - that's his profit. The customer buys it because it is worth more to him than he pays for it - that's his profit.

11

ATMOSPHERES OF BUSINESS AND RETAIL

12

1.Research & development.

2.Product Approval.

3.Marketing.

4.Industry Revenue:-For the first time ever, in 2006, global spending on prescription drugs topped $643 billion, even as growth slowed somewhat in Europe and North America. The United States accounts for almost half of the globalpharmaceutical market, with $289 billion in annual sales followed by the EU and Japan Emerging markets such as China, Russia, South Korea and Mexico outpaced that market, growing a huge 81 percent.

.

13

GROUP MEMBERS

• ADITYA LADHA (07)

• NEHA GUGLANI (60)

• PARAMVEER SINGH ( 67)

14